i
048530
vs
K
KOSPI 200
Over the past 12 months, iNtRON Biotechnology Inc has underperformed KOSPI 200, delivering a return of +17% compared to the KOSPI 200's +114% growth.
Stocks Performance
048530 vs KOSPI 200
Performance Gap
048530 vs KOSPI 200
Performance By Year
048530 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
iNtRON Biotechnology Inc
Glance View
iNtRON Biotechnology, Inc. is a Korea-based company principally engaged in the biotechnology industry. The Company operates its business through two main divisions: genetic reagent division and molecular diagnostics division. Its genetic reagent division is involved in the research and development of reagents, which are under the brand names of Maxime and pLUG for life science research. Its molecular diagnostics division is engaged in the development and production of nucleic acid tester for infectious diseases. It also engages in the operation of veterinary antibiotic alternative business and new biopharmaceuticals development business. The Company distributes its products within domestic market and to overseas markets.
